GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ultragenyx Pharmaceutical Inc (STU:UP0) » Definitions » 6-1 Month Momentum %

Ultragenyx Pharmaceutical (STU:UP0) 6-1 Month Momentum % : 11.17% (As of May. 17, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Ultragenyx Pharmaceutical 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-05-17), Ultragenyx Pharmaceutical's 6-1 Month Momentum % is 11.17%.

The industry rank for Ultragenyx Pharmaceutical's 6-1 Month Momentum % or its related term are showing as below:

STU:UP0's 6-1 Month Momentum % is ranked better than
60.03% of 1531 companies
in the Biotechnology industry
Industry Median: -3.11 vs STU:UP0: 11.17

Competitive Comparison of Ultragenyx Pharmaceutical's 6-1 Month Momentum %

For the Biotechnology subindustry, Ultragenyx Pharmaceutical's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ultragenyx Pharmaceutical's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ultragenyx Pharmaceutical's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Ultragenyx Pharmaceutical's 6-1 Month Momentum % falls into.



Ultragenyx Pharmaceutical  (STU:UP0) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ultragenyx Pharmaceutical  (STU:UP0) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Ultragenyx Pharmaceutical 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Ultragenyx Pharmaceutical's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ultragenyx Pharmaceutical (STU:UP0) Business Description

Traded in Other Exchanges
Address
60 Leveroni Court, Novato, CA, USA, 94949
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.

Ultragenyx Pharmaceutical (STU:UP0) Headlines

No Headlines